Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

ALMA - Pioneering Smart Lens to Revolutionize Eye Care

Objectif

Nearly 5M people in the EU, the UK, and the US are affected by irregular corneas, a condition characterized by imperfections on the corneal surface. Irregular corneas disrupt the smooth, regular structure needed to focus light evenly onto the retina, leading to distorted or blurry vision. This condition can result from various causes, including diseases, injuries, or previous surgeries. Patients with irregular corneas often experience significant visual disturbances and may struggle with glare, halos, and night vision issues.
Treatment options range from spectacles and various contact lenses to more invasive procedures like corneal transplants. The current state-of-the-art solutions, including rigid scleral lenses, often fail to fully address higher order aberrations, leaving patients with persistent vision problems.
After 10+ years of research and breakthroughs in smart contact lens design, construction, and operation, Azalea has developed ALMA, the first patented autonomous and adaptable Smart Lens for patients with irregular corneas. This revolutionary solution integrates advanced light management technology into a scleral lens platform, featuring a dynamic light filter, a custom microchip, and a wireless smart case for charging and disinfection. ALMA provides improved visual quality, enhanced comfort, and real-time adaptation to environmental conditions, offering a new standard of care for patients with irregular corneas.
With EIC’s support, Azalea plans to conduct First-in-Human and pivotal clinical trials to obtain CE mark and FDA approvals for the commercialization of the ALMA Smart Lens. Our initial focus is on the irregular cornea market across Europe, the UK, and the US. This market encompasses a total addressable population of 614k patients with irregular corneas, representing a market opportunity of €3B. The project is expected to significantly impact Azalea, projecting €130M in revenues and reaching 135 employees within 5 years of commercialization.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-EIC-2026-ACCELERATOR-02

Voir tous les projets financés au titre de cet appel

Coordinateur

AZALEA VISION
Contribution nette de l'UE
€ 2 498 825,00
Adresse
TECHNOLOGIEPARK-ZWIJNAARDE 122
9052 GAND
Belgique
PME
Oui
Région
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
Aucune donnée